Search for:
  • Sign in
  • Register
  • Country Reports
  • Interviews
  • InFocus
  • Europe
  • Asia-Pacific
  • Americas
  • Middle East & Africa
  • Legal & Regulatory
  • Facts & Figures
  • Library
  • Op-eds
  • Shop
Monday, June 9, 2025
PharmaBoardroom
Sign In Register
  • Home
  • Country Reports
    • All
    • Americas
    • Asia-Pacific
    • Europe
    • Middle East & Africa
  • Exclusive interviews
    • All
    • Latest
    • Americas
    • Asia-Pacific
    • Europe
    • Middle East & Africa
  • Articles
    • All
    • Global
    • Latest
  • Legal & Regulatory
    • All
    • The Pharma Legal Handbook
    • Regulatory, Pricing and Reimbursement
    • Marketing, Manufacturing, Packaging and Labeling
    • Preclinical and Clinical Trials
  • Op-Eds & Contributions
  • InFigures
    • All
    • Rankings
    • Americas
    • Asia-Pacific
    • Europe
    • Middle East & Africa
  • Library
    • All
    • InFocus
    • InFigures
    • White Papers
  • Media Kit
  • Register
  • About Us
  • Country Reports
  • Interviews
  • InFocus
  • Europe
  • Asia-Pacific
  • Americas
  • Middle East & Africa
  • Legal & Regulatory
  • Facts & Figures
  • Library
  • Op-eds
  • Shop
Spain Pharma Report September 2019 Download

Spain,

September 2019

Building on the topics covered in our March 2019 report, this latest edition of Healthcare & Life Sciences Review Spain takes a closer look at the broader Spanish life sciences value chain.

With the Iberian nation enjoying an economic rebound, pharmaceutical multinationals are once again seeing Spain as a favourable investment destination, taking into account the country’s Swiss or German quality levels at southern European prices. Indeed, recent years have seen big ticket infrastructural investments in Spanish manufacturing plants from the likes of Pfizer, Takeda and Bayer.

This trend is also prevalent in the medical devices sphere, with Becton Dickinson and B Braun, to name but two, looking once more to Spain.

Medtech firms are also at the forefront of another key trend tackled in this report: Spain’s move towards a value-based healthcare model and how public and private actors are interacting to create innovative and digital solutions.

Other topics touched on in this comprehensive and wide-ranging report include how the region of Catalonia is forging ahead in healthcare innovation, why Spain is increasingly a happy hunting ground for resourceful generics firms, and how players in niches as diverse as dermo-cosmetics and bugtech are achieving Spanish success.

Building on the topics covered in our March 2019 report, this latest edition of Healthcare & Life Sciences Review Spain takes a closer look at the broader Spanish life sciences value chain.

With the Iberian nation enjoying an economic rebound, pharmaceutical multinationals are once again seeing Spain as a favourable investment destination, taking into account the country’s Swiss or German quality levels at southern European prices. Indeed, recent years have seen big ticket infrastructural investments in Spanish manufacturing plants from the likes of Pfizer, Takeda and Bayer.

This trend is also prevalent in the medical devices sphere, with Becton Dickinson and B Braun, to name but two, looking once more to Spain.

Medtech firms are also at the forefront of another key trend tackled in this report: Spain’s move towards a value-based healthcare model and how public and private actors are interacting to create innovative and digital solutions.

Other topics touched on in this comprehensive and wide-ranging report include how the region of Catalonia is forging ahead in healthcare innovation, why Spain is increasingly a happy hunting ground for resourceful generics firms, and how players in niches as diverse as dermo-cosmetics and bugtech are achieving Spanish success.

See more

Legal & Regulatory

report
Buy
Tags:
Spain, Pharma, Report
Share on Facebook Share on WhatsApp Share on Twitter Share on Linkedin Share in Email
Back
PharmaBoardroom

PharmaBoardroom Limited
Evolution House
Iceni Court, Delft Way,
Norwich, NR6 6BB UK

Latest

  • Articles
  • In Conversation
  • Facts & Figures
  • Country Reports
  • Legal & Regulatory
  • InFocus

More

  • About Us

Join Us

  • Email Newsletters
  • LinkedIn

Contact

+44 2078673717

info@stage.pharma.kalyna.dev

Legal & Privacy

  • Terms and Conditions
  • Privacy and Cookies policy
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here

logo

Sign in

Forgot password? Register Now